|Articles|February 9, 2022
- Pharmaceutical Executive-02-01-2022
- Volume 42
- Issue 2
Pharmaceutical Executive, February 2022 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive February 2022 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 4 years ago
As Change Continues, Are You Digitally Fit For the Future?almost 4 years ago
Ready for Pharma’s Next Chapteralmost 4 years ago
The Tech Perspective: Coordinating a Plan of Engagementalmost 4 years ago
The Importance of Culturally Inclusive and Relevant Marketingalmost 4 years ago
Messaging Makeoveralmost 4 years ago
Ethics of Antibioticsalmost 4 years ago
What’s Up in Biotech These Days? Not Much, Unfortunatelyalmost 4 years ago
Planning for Second to Market in Orphan Disease Spacealmost 4 years ago
AI and Analytics Appear Ready to Surge in Sales and Marketingalmost 4 years ago
It’s Time for Companies To See Employees as Full-Time PeopleNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Your Phase III Clinical Protocol Is Your Initial Product Launch
2
Pharmaceutical Executive Daily: Public Citizen Sues The Trump Administration Over Undisclosed Drug Price Agreements
3
AstraZeneca Enters $4.7 Billion Collaboration Agreement with CSPC Pharmaceuticals
4
Taking Advantage of ‘Hidden Gem’ Talent Hubs
5

